Search

everythinglearnresearchcommunity

for

Search:↓

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Mice with a Gsdma3 gene mutation have thicker skin and longer hair follicle openings due to increased β-catenin levels.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Hormonal therapies might help treat hidradenitis suppurativa, but treatment is complex and personalized.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Finasteride's molecular properties and active sites were identified using computational methods.

A woman developed male characteristics after using unregulated hormone therapy.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Hair samples can reliably show average long-term hormone levels in young women.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.